CONVERGE-01: Dosimetry, randomized dose optimization, dose escalation and efficacy of Ac-225 rosopatamab tetraxetan in participants with PSMA-positive castration-resistant prostate cancer Meeting Abstract

  


Authors: Pandit-taskar, N.; Morris, M.; Kiess, A.; Nordquist, L.; Gupta, S.; George, D.; Antonarakis, E.; Messmann, R.; Kantoff, P.; Vallabhajosula, S.; Nauseef, J.; Bander, N.; Cayci, Z.
Abstract Title: CONVERGE-01: Dosimetry, randomized dose optimization, dose escalation and efficacy of Ac-225 rosopatamab tetraxetan in participants with PSMA-positive castration-resistant prostate cancer
Meeting Title: 2025 SNMMI Annual Meeting
Journal Title: Journal of Nuclear Medicine
Volume: 66
Issue: Suppl. 1
Meeting Dates: 2025 Jun 21-24
Meeting Location: New Orleans, LA
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2025-06-03
Language: English
ACCESSION: WOS:001554678000035
PROVIDER: wos
Notes: Meeting Abstract: 251387 -- Source: Wos